Oncotype DX genomic testing suite for richmond VAMC

Ended Awarded Last action

Contract number
36C24621F0006
Awardee
Awarding agency
Obligated
$295,658

Award facts

Contract value 82% obligated
  • $295,657.70 Current, with exercised options
  • $360,296.94 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Redwood City, CA 94063, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00017 -$17,270
Supplemental Agreement for work within scope P00016 -$14,235
Supplemental Agreement for work within scope P00015 -$42,785
Funding Only Action P00014 $17,270
Exercise an Option P00013 $0
Supplemental Agreement for work within scope P00012 -$27,055
Exercise an Option P00011 $87,583
Exercise an Option P00010 $0
Supplemental Agreement for work within scope P00009 $21,584
Supplemental Agreement for work within scope P00008 -$32,320
Exercise an Option P00007 $56,497
Exercise an Option P00006 $0
Funding Only Action P00005 -$178,804
Supplemental Agreement for work within scope P00004 -$35,833
Exercise an Option P00003 $56,497
Exercise an Option P00002 $0
Funding Only Action P00001 $348,029
Original award $56,497
Show all 18

About this award

Written by GovTribe AI ·

This delivery order, awarded October 1, 2020, provides Oncotype DX genomic testing services to the Richmond Veterans Affairs Medical Center through Veterans Integrated Service Network 6. Exact Sciences Corporation, through its Exact Sciences Laboratories division, will deliver advanced cancer genomic assays under this firm fixed-price contract valued at $360,296.94, with performance extending through September 30, 2025. The contract operates under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), which establishes the framework for federal agencies to procure specialized medical diagnostic testing services. This award carries no set-aside designation, indicating Exact Sciences competed in the open market based on its established capabilities in genomic testing and cancer diagnostics.

Exact Sciences Corporation has positioned itself as a key provider of oncology diagnostic services across the Department of Veterans Affairs and broader federal healthcare system, leveraging its expertise in gene expression profiling and molecular diagnostics. The company holds multiple blanket purchase agreements and indefinite delivery vehicles across VA medical centers and the Defense Health Agency, with several agreements valued in the millions of dollars for similar Oncotype DX testing services. Through this contract with Richmond VAMC and its related federal healthcare agreements, Exact Sciences delivers personalized medicine support to veterans, enabling clinicians to make informed treatment decisions for breast, prostate, and colorectal cancer patients.

Quick answers

Who was awarded contract 36C24621F0006?

36C24621F0006 was awarded to Exact Sciences Corporation by Veterans Integrated Service Network 6 (Veterans Health Administration) on October 1, 2020.

How much is contract 36C24621F0006 worth?

The government has obligated $295,658 on 36C24621F0006. Its potential value, with all options, is $360,297.

Is contract 36C24621F0006 an order under another contract?

Yes. 36C24621F0006 is a delivery order under V797D70053, a federal supply schedule, on Medical Laboratory Testing and Analysis Services (FSS-621-II).

Was contract 36C24621F0006 competed?

The extent of competition for 36C24621F0006 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login